BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33517239)

  • 21. Markers of bone turnover in patients with epilepsy and their relationship to management of bone diseases induced by antiepileptic drugs.
    Hamed SA
    Expert Rev Clin Pharmacol; 2016; 9(2):267-86. PubMed ID: 26589104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for bone health in epilepsy.
    Sheth RD; Harden CL
    Epilepsia; 2007; 48 Suppl 9():39-41. PubMed ID: 18047601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs.
    Kulak CA; Borba VZ; Bilezikian JP; Silvado CE; Paola Ld; Boguszewski CL
    Arq Neuropsiquiatr; 2004 Dec; 62(4):940-8. PubMed ID: 15608949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy.
    Joshi R; Tripathi M; Gupta P; Gulati S; Gupta YK
    Indian J Med Res; 2017 Mar; 145(3):317-326. PubMed ID: 28749393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive bone deficit in epilepsy.
    Sheth RD; Binkley N; Hermann BP
    Neurology; 2008 Jan; 70(3):170-6. PubMed ID: 18057319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy.
    Lyngstad-Brechan MA; Taubøll E; Nakken KO; Gjerstad L; Godang K; Jemtland R; Bollerslev J
    Scand J Clin Lab Invest; 2008; 68(8):759-66. PubMed ID: 18618370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone loss associated with use of antiepileptic drugs.
    Nakken KO; Taubøll E
    Expert Opin Drug Saf; 2010 Jul; 9(4):561-71. PubMed ID: 20201711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-epileptic medication and bone health.
    Petty SJ; O'Brien TJ; Wark JD
    Osteoporos Int; 2007 Feb; 18(2):129-42. PubMed ID: 17091219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country.
    Phabphal K; Limapichat K; Sathirapanya P; Setthawatcharawanich S; Leelawattana R; Thammakumpee N; Thamaprasit A; Geater A
    Epileptic Disord; 2008 Sep; 10(3):213-8. PubMed ID: 18782690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How safe is bone health in patients on newer or enzyme inhibitor antiepileptic drugs?
    Mitta N; Rajiv KR; Baishya J; Chandran A; Menon R; Thomas SV; Radhakrishnan A
    J Neurol Sci; 2019 Oct; 405():116422. PubMed ID: 31415951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
    Hansen RN; Nguyen HP; Sullivan SD
    Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone health in people with epilepsy: is it impaired and what are the risk factors?
    Pack A
    Seizure; 2008 Mar; 17(2):181-6. PubMed ID: 18187347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in bone turnover, bone mineral and fracture risk induced by drugs used to treat epilepsy.
    Vestergaard P
    Curr Drug Saf; 2008 Sep; 3(3):168-72. PubMed ID: 18690996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone loss with antiepileptic drug therapy: a twin and sibling study.
    Shiek Ahmad B; Petty SJ; Gorelik A; O'Brien TJ; Hill KD; Christie JJ; Sambrook PN; Wark JD
    Osteoporos Int; 2017 Sep; 28(9):2591-2600. PubMed ID: 28589417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment].
    Bartl R
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1475-9. PubMed ID: 17583832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic concerns associated with antiepileptic medications.
    Sheth RD
    Neurology; 2004 Nov; 63(10 Suppl 4):S24-9. PubMed ID: 15557547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired bone and muscle development in young people treated with antiepileptic drugs.
    Simm PJ; Seah S; Gorelik A; Gilbert L; Nuguid J; Werther GA; Mackay MT; Freeman JL; Petty SJ; Wark JD
    Epilepsia; 2017 Nov; 58(11):1931-1938. PubMed ID: 28880998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture risk associated with use of antiepileptic drugs.
    Vestergaard P; Rejnmark L; Mosekilde L
    Epilepsia; 2004 Nov; 45(11):1330-7. PubMed ID: 15509233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
    Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
    Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.